MC
IBB icon

Moors & Cabot’s iShares Biotechnology ETF IBB Stock Holding History

Moors & Cabot’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-30,000
Closed -$30K – 656
2019
Q3 		$30K Buy
+30,000
New +$3.14M ﹤0.01% 625

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Moors & Cabot's IBB Position: Q1 2026 in Review

Moors & Cabot held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 9,041 shares worth $1.53M. The position accounts for 0.07% of the portfolio, ranked #265.

Moors & Cabot first reported a position in IBB in Q1 2014 and has held it in 43 quarters since. The position peaked at $4.57M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Moors & Cabot held 9,041 shares of iShares Biotechnology ETF worth $1.53M as of Q1 2026.
  • Moors & Cabot left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.07% of Moors & Cabot's portfolio in Q1 2026, its #265 holding.
  • Moors & Cabot first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 43 quarters since.
  • Moors & Cabot's iShares Biotechnology ETF position peaked at $4.57M in Q2 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.